Skopos Labs, Inc. Xencor Inc Transaction History
Skopos Labs, Inc.
- $497 Million
- Q2 2025
A detailed history of Skopos Labs, Inc. transactions in Xencor Inc stock. As of the latest transaction made, Skopos Labs, Inc. holds 879 shares of XNCR stock, worth $12,042. This represents 0.0% of its overall portfolio holdings.
Number of Shares
879
Previous 879
-0.0%
Holding current value
$12,042
Previous $9,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding XNCR
# of Institutions
210Shares Held
81.9MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY11.1MShares$152 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA10.5MShares$144 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.62MShares$118 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.14MShares$84.2 Million4.16% of portfolio
-
State Street Corp Boston, MA3.82MShares$52.3 Million0.0% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $818M
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...